{
    "nctId": "NCT03085888",
    "briefTitle": "The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types",
    "officialTitle": "The STRIVE Study: Breast Cancer Screening Cohort for the Development of Assays for Early Cancer Detection",
    "overallStatus": "COMPLETED",
    "conditions": "Neoplasms, Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 99481,
    "primaryOutcomeMeasure": "To evaluate the performance of the pre-specified GRAIL Test to detect invasive cancers (including hematologic malignancies).",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women undergoing mammography for screening indications or have an appointment for screening mammography.\n2. Participant provides informed consent and expresses understanding of the protocol and its requirements, risks, and discomforts.\n\nExclusion Criteria:\n\nNone.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}